Gene · 6607
Papers3,510
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 3,510
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cost-effectiveness of treatments for presymptomatic newborn patients with spinal muscular atrophy and two or three copies of the survival motor neuron 2 gene in Italy. | Eur J Health Econ | 2026 | 40569556 | PubTator, text mining | PubMed |
| An induced pluripotent stem cell-based chemical genetic approach for studying spinal muscular atrophy. | Front Neurosci | 2025 | 41716912 | PubTator, text mining | PubMed |
| Circulating Tau Profiles in Pediatric and Adult Patients with Spinal Muscular Atrophy. | medRxiv | 2025 | 41607656 | PubTator, text mining | PubMed |
| The role of super-enhancer-driven lncRNAs in cancer. | Comput Struct Biotechnol J | 2025 | 41542082 | PubTator, text mining | PubMed |
| [Pharmacoeconomic evaluation of spinal muscular atrophy therapy in patients with four SMN2 copies diagnosed through newborn screening]. | Zh Nevrol Psikhiatr Im S S Korsakova | 2025 | 41524367 | PubTator, text mining | PubMed |
| Abstracts of the Annual Meeting of the Iuliu HaţieganuUniversity of Medicine and Pharmacy: 8th - 13th December 2025, Cluj-Napoca. | Med Pharm Rep | 2025 | 41496885 | PubTator, text mining | PubMed |
| Microvascular pathology in the spinal cord of severe spinal muscular atrophy patients. | Res Sq | 2025 | 41377955 | PubTator, text mining | PubMed |
| DistRMI: a deep distance-aware neural network for explainable RNA loop motif-small molecule interaction prediction. | Brief Bioinform | 2025 | 41364671 | PubTator, text mining | PubMed |
| Comprehensive Overview of Computational Tools for Alternative Splicing Analysis. | Wiley Interdiscip Rev RNA | 2025 | 41326318 | PubTator, text mining | PubMed |
The Integrated Approach in Patients with Spinal Muscular Atrophy in the Era of Early Diagnosis, Etiopathogenic Therapies and Multidisciplinary Standards of Care and Rehabilitation Interventions Leads to New Phenotypes. | Life (Basel) | 2025 | 41302155 | PubTator, text mining | PubMed |
| A neural substrate for sensory over-responsivity defined by exogenous and endogenous brain systems. | J Neurodev Disord | 2025 | 41266974 | PubTator, text mining | PubMed |
| Course of joint range of motion in children with spinal muscular atrophy receiving disease-modifying treatment. | Orphanet J Rare Dis | 2025 | 41257785 | PubTator, text mining | PubMed |
| An Autopsy Case of ALS Which Clinically Presented Sporadic Adult-Onset Lower Motor Neuron Disease and Genetically Had p. Leu127Ser (L126S) Variant in SOD1 and SMN2 Deletion. | Neuropathology | 2025 | 41239785 | PubTator, text mining | PubMed |
| Efficacy and safety of risdiplam in adults with 5q-associated spinal muscular atrophy: a nationwide observational cohort study in Austria. | EClinicalMedicine | 2025 | 41181835 | PubTator, text mining | PubMed |
| Application of whole genome sequencing for carrier and diagnostic assessment of spinal muscular atrophy in Taiwan. | NPJ Genom Med | 2025 | 41162409 | PubTator, text mining | PubMed |
| Advances in Methods for Accurate Prediction of RNA-Small Molecule Binding Sites: From Isolated to AI-Integrated Strategies. | Pharmaceuticals (Basel) | 2025 | 41155705 | PubTator, text mining | PubMed |
Validation on the First-Tier Fully Automated High-Throughput SMN1, SMN2, TREC, and RPP30 Quantification by Quadruplex Droplet Digital PCR for Newborn Screening for Spinal Muscular Atrophy and Severe Combined Immunodeficiency. | Int J Neonatal Screen | 2025 | 41133709 | PubTator, text mining | PubMed |
| Quebec Spinal Muscular Atrophy Newborn Screening Program: The First Year Experience. | Int J Neonatal Screen | 2025 | 41133701 | PubTator, text mining | PubMed |
| A Chemically Induced CRISPR/dCas13FCPF Platform for Precise and Programmable RNA Regulation. | J Med Chem | 2025 | 41122778 | PubTator, text mining | PubMed |
| Differences in swallowing efficacy of disease modifying treatment between infants receiving pre-symptomatic and symptomatic administration. | Orphanet J Rare Dis | 2025 | 41121134 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6607/papers?page=7